Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030082 | SCV000052737 | benign | Maturity-onset diabetes of the young type 4 | 2011-08-18 | criteria provided, single submitter | clinical testing | Converted during submission to Benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030084 | SCV000052739 | uncertain | Neonatal diabetes mellitus | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Uncertain significance. |
Eurofins Ntd Llc |
RCV000261035 | SCV000332347 | benign | not specified | 2015-06-25 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV000445549 | SCV000537093 | benign | Monogenic diabetes | 2018-12-07 | criteria provided, single submitter | research | ACMG criteria: BP4 (CADD and indel predictor PROVEAN calls neutral, DDIG-indel 90% probability that it is neurtal), BA1 (7.5% in African and 38 homo in gnomAD), PM4 (nonframeshift protein length changing), PS3 (decrease in insulin promoter activity, PMID: 10545531), PP1mod (2 familes with 5 individuals each segregating, PMID: 10545531- 1999 paper, only looked at PDX1 variant)--> conflicting data BUT 7.5% in African --> BA1= benign |
Labcorp Genetics |
RCV000959390 | SCV001106293 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000030082 | SCV001138926 | benign | Maturity-onset diabetes of the young type 4 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000261035 | SCV001476621 | benign | not specified | 2019-10-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000959390 | SCV001916107 | benign | not provided | 2019-01-10 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16229747, 17003361, 14764823, 10545531, 27634015) |
Ambry Genetics | RCV002381270 | SCV002672498 | benign | Maturity onset diabetes mellitus in young | 2017-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000959390 | SCV004563019 | benign | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | |
OMIM | RCV002279932 | SCV000029629 | risk factor | Diabetes mellitus type 2, susceptibility to | 1999-11-01 | no assertion criteria provided | literature only |